Stocks In News - USFDA

1. Strides Pharma Science  has  received zero observations from USFDA.
2. The company has received the establishment inspection report (EIR) for its Bangalore facility, there by confirming the successful closure of the inspections.
3. The company’s formulations facility (KRSG Gardens) in Bangalore inspected by the USFDA in August 2018 and November 2018 had concluded with Zero 483 observations.
4. The facility in Bangalore manufacturers tablets, capsules, liquids, creams ointments, sachets.